Similar results were obtained from liver biopsies of patients with FLD and NASH, with increased TRIM21 levels in NASH and reduced A1CF and KHK-C protein levels (Figure 2D). Here, A1CF is linked to metabolic dysfunction-associated steatohepatitis.